Cargando…

Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study

Objective To examine the effect of β blockers in the management of chronic obstructive pulmonary disease (COPD), assessing their effect on mortality, hospital admissions, and exacerbations of COPD when added to established treatment for COPD. Design Retrospective cohort study using a disease specifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Short, Philip M, Lipworth, Samuel I W, Elder, Douglas H J, Schembri, Stuart, Lipworth, Brian J
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091487/ https://www.ncbi.nlm.nih.gov/pubmed/21558357 http://dx.doi.org/10.1136/bmj.d2549

Ejemplares similares

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
por: Lipworth, Brian, et al.
Publicado: (2016)

Is Gly16Arg β(2) Receptor Polymorphism Related to Impulse Oscillometry in a Real-Life Asthma Clinic Setting?
por: Jabbal, Sunny, et al.
Publicado: (2016)

Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD
por: Jabbal, Sunny, et al.
Publicado: (2017)

The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK
por: Edwards, Susan C, et al.
Publicado: (2016)

Bisoprolol versus celiprolol on dynamic hyperinflation, cardiopulmonary exercise and domiciliary safety in COPD: a single-centre, randomised, crossover study
por: Anderson, William, et al.
Publicado: (2023)

Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)
por: Cotton, Seonaidh, et al.
Publicado: (2022)

Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study
por: Morales, Daniel R., et al.
Publicado: (2017)

Glycopyrrolate/formoterol fumarate metered dose inhaler for maintenance-naïve patients with chronic obstructive pulmonary disease: a post-hoc analysis of the randomized PINNACLE trials
por: Zheng, Jinping, et al.
Publicado: (2020)

Benefit:Risk Profile of Budesonide in Obstructive Airways Disease
por: Tashkin, Donald P., et al.
Publicado: (2019)

Increase use of β-blockers in patients with chronic obstructive pulmonary and cardiovascular disease
por: Yang, Yan-Li, et al.
Publicado: (2021)

Oscillometry bronchodilator response in adult moderate to severe eosinophilic asthma patients: A prospective cohort study
por: Chan, Rory, et al.
Publicado: (2022)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection
por: Lipworth, Brian, et al.
Publicado: (2020)

Chronic obstructive pulmonary disease and β‐blocker treatment in Asian patients with heart failure
por: Kubota, Yoshiaki, et al.
Publicado: (2017)

Different Non-selective β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2019)

Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease
por: Verdecchia, Paolo, et al.
Publicado: (2021)

Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease—The Shifting Treatment Paradigm
por: Wilkie, Morven, et al.
Publicado: (2015)

Allopurinol in Patients with Pulmonary Hypertension Associated with Chronic Lung Disease
por: Liu-Shiu-Cheong, Patrick S K, et al.
Publicado: (2020)

Don’t Forget about Facilitatory Effects of Corticosteroids on β(2)-Adrenoceptors in Acute Asthma
por: Lipworth, Brian, et al.
Publicado: (2020)

β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol
por: Bhatt, Surya P, et al.
Publicado: (2016)

Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease
por: Zvizdic, Faris, et al.
Publicado: (2019)

The role of pulmonary arterial stiffness in COPD
por: Weir-McCall, Jonathan R., et al.
Publicado: (2015)

Effect of Perioperative β-Blockers on Pulmonary Complications among Patients with Chronic Obstructive Pulmonary Disease Undergoing Lung Resection Surgery
por: Kamath, A., et al.
Publicado: (2015)

Impact of Biologic Therapy on the Small Airways Asthma Phenotype
por: Chan, Rory, et al.
Publicado: (2022)

Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma
por: Chan, Rory, et al.
Publicado: (2023)

Phenotypic associations of medical polypectomy and revision surgery following endoscopic sinus surgery: a retrospective study of a single-centre experience in Scotland
por: Misirovs, Rasads, et al.
Publicado: (2023)

Intolerance to Angiotensin Converting Enzyme Inhibitors in Asthma and the General Population: A UK Population-Based Cohort Study
por: Morales, Daniel R., et al.
Publicado: (2021)

Normal spirometry equates to normal impulse oscillometry in healthy subjects
por: Lipworth, Brian, et al.
Publicado: (2021)

Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations
por: Chan, Rory, et al.
Publicado: (2022)

Medium-term repeatability for airwave oscillometry in patients with severe asthma taking benralizumab
por: Chan, Rory, et al.
Publicado: (2023)

Disconnect for Tezepelumab on Exacerbations, Symptoms, and Quality of Life in Type 2 Low Asthma
por: Lipworth, Brian, et al.
Publicado: (2023)

Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease
por: Kubota, Yoshiaki, et al.
Publicado: (2015)

Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study
por: Dong, Yaa-Hui, et al.
Publicado: (2017)

Reddit and Google Activity Related to Non-COVID Epidemic Diseases Surged at Start of COVID-19 Pandemic: Retrospective Study
por: Cummins, Jack A, et al.
Publicado: (2023)

Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality – The STATUETTE Cohort Study
por: Damkjær, Mathias, et al.
Publicado: (2021)

Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis
por: Yang, Yan-Li, et al.
Publicado: (2020)

Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions
por: Albouaini, Khaled, et al.
Publicado: (2007)

β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease – A Danish Nationwide Study of 1·3 Million Individuals
por: Nielsen, Anne Orholm, et al.
Publicado: (2019)

Beyond Duty: Medical “Heroes” and the COVID-19 Pandemic
por: Lipworth, Wendy
Publicado: (2020)

Real-world Data to Generate Evidence About Healthcare Interventions: The Application of an Ethics Framework for Big Data in Health and Research
por: Lipworth, Wendy
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eio65lsime2fa63i3q56rdevft